HEADER OXIDOREDUCTASE 24-SEP-20 7AH5 TITLE CRYSTAL STRUCTURE OF INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IN COMPLEX TITLE 2 WITH FERRIC HEME AND MMG-0706 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDOLEAMINE 2,3-DIOXYGENASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IDO-1,INDOLEAMINE-PYRROLE 2,3-DIOXYGENASE; COMPND 5 EC: 1.13.11.52; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IDO1, IDO, INDO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA DE3 KEYWDS OXIDOREDUCTASE, DIOXYGENASE, HEME-CONTAINING ENZYME, STRUCTURE-BASED KEYWDS 2 DRUG DESIGN, IDO1 INHIBITOR, TRIAZOLE, SMALL-MOLECULE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR U.F.ROEHRIG,A.REYNAUD,F.POJER,O.MICHIELIN,V.ZOETE REVDAT 5 23-OCT-24 7AH5 1 REMARK REVDAT 4 31-JAN-24 7AH5 1 REMARK REVDAT 3 10-MAR-21 7AH5 1 JRNL REVDAT 2 24-FEB-21 7AH5 1 JRNL REVDAT 1 17-FEB-21 7AH5 0 JRNL AUTH U.F.ROHRIG,S.R.MAJJIGAPU,A.REYNAUD,F.POJER,N.DILEK, JRNL AUTH 2 P.REICHENBACH,K.ASCENCAO,M.IRVING,G.COUKOS,P.VOGEL, JRNL AUTH 3 O.MICHIELIN,V.ZOETE JRNL TITL AZOLE-BASED INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) INHIBITORS. JRNL REF J.MED.CHEM. V. 64 2205 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33557523 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01968 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.55 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 23363 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.530 REMARK 3 FREE R VALUE TEST SET COUNT : 1992 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.5530 - 6.9820 1.00 1659 152 0.2015 0.2295 REMARK 3 2 6.9820 - 5.5448 0.99 1568 145 0.2437 0.2697 REMARK 3 3 5.5448 - 4.8447 1.00 1551 145 0.2091 0.2680 REMARK 3 4 4.8447 - 4.4021 1.00 1551 145 0.1939 0.2451 REMARK 3 5 4.4021 - 4.0868 1.00 1519 142 0.2080 0.3023 REMARK 3 6 4.0868 - 3.8460 0.99 1531 142 0.2171 0.3123 REMARK 3 7 3.8460 - 3.6534 0.99 1523 143 0.2671 0.3284 REMARK 3 8 3.6534 - 3.4945 0.99 1508 141 0.2795 0.3541 REMARK 3 9 3.4945 - 3.3600 1.00 1524 143 0.2563 0.3392 REMARK 3 10 3.3600 - 3.2441 1.00 1505 139 0.2670 0.3716 REMARK 3 11 3.2441 - 3.1426 1.00 1510 141 0.2799 0.4027 REMARK 3 12 3.1426 - 3.0528 1.00 1529 143 0.2863 0.3782 REMARK 3 13 3.0528 - 2.9725 1.00 1523 143 0.3016 0.3710 REMARK 3 14 2.9725 - 2.9000 0.92 1370 128 0.3373 0.4031 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.490 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.580 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AH5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1292111312. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-DEC-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23435 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 46.553 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.01 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2D0T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 8000, 10% PEG 1000, 0.2 M REMARK 280 POTASSIUM THIOCYANATE, 0.1 M TRIS PH 7.5, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.49400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.18000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.55300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.18000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.49400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.55300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 ALA A 4 REMARK 465 MET A 5 REMARK 465 GLU A 6 REMARK 465 ASN A 7 REMARK 465 SER A 8 REMARK 465 TRP A 9 REMARK 465 THR A 10 REMARK 465 ILE A 11 REMARK 465 SER A 12 REMARK 465 PRO A 362 REMARK 465 LYS A 363 REMARK 465 GLU A 364 REMARK 465 ASN A 365 REMARK 465 LYS A 366 REMARK 465 THR A 367 REMARK 465 SER A 368 REMARK 465 GLU A 369 REMARK 465 ASP A 370 REMARK 465 PRO A 371 REMARK 465 SER A 372 REMARK 465 LYS A 373 REMARK 465 LEU A 374 REMARK 465 GLU A 375 REMARK 465 ALA A 376 REMARK 465 LYS A 377 REMARK 465 GLY A 378 REMARK 465 THR A 379 REMARK 465 GLY A 380 REMARK 465 GLY A 403 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 ALA B 4 REMARK 465 MET B 5 REMARK 465 GLU B 6 REMARK 465 ASN B 7 REMARK 465 SER B 8 REMARK 465 TRP B 9 REMARK 465 THR B 10 REMARK 465 ILE B 11 REMARK 465 GLN B 361 REMARK 465 PRO B 362 REMARK 465 LYS B 363 REMARK 465 GLU B 364 REMARK 465 ASN B 365 REMARK 465 LYS B 366 REMARK 465 THR B 367 REMARK 465 SER B 368 REMARK 465 GLU B 369 REMARK 465 ASP B 370 REMARK 465 PRO B 371 REMARK 465 SER B 372 REMARK 465 LYS B 373 REMARK 465 LEU B 374 REMARK 465 GLU B 375 REMARK 465 ALA B 376 REMARK 465 LYS B 377 REMARK 465 GLY B 378 REMARK 465 THR B 379 REMARK 465 GLU B 402 REMARK 465 GLY B 403 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 27 77.37 48.57 REMARK 500 ASP A 34 -8.22 -59.24 REMARK 500 HIS A 69 31.59 -88.12 REMARK 500 VAL A 130 -56.21 -129.07 REMARK 500 ASN A 133 53.75 -115.45 REMARK 500 PHE A 154 -61.12 -95.63 REMARK 500 VAL A 229 -71.18 -116.33 REMARK 500 GLN A 280 95.63 -66.79 REMARK 500 ILE A 354 -55.39 -135.41 REMARK 500 GLN A 360 55.95 -144.93 REMARK 500 LEU A 400 71.13 -68.49 REMARK 500 LYS B 13 -165.00 -123.19 REMARK 500 GLU B 14 22.93 -77.32 REMARK 500 TYR B 15 10.53 -65.80 REMARK 500 ASN B 27 70.72 46.73 REMARK 500 VAL B 130 -52.55 -129.80 REMARK 500 ASN B 140 49.87 -108.80 REMARK 500 PRO B 142 -166.27 -71.14 REMARK 500 LEU B 143 74.95 -114.63 REMARK 500 PHE B 154 -61.92 -94.95 REMARK 500 VAL B 229 -54.49 -131.87 REMARK 500 TRP B 237 51.33 -115.40 REMARK 500 PHE B 252 -62.44 -100.88 REMARK 500 SER B 312 37.72 -88.11 REMARK 500 ILE B 354 -54.78 -133.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 346 NE2 REMARK 620 2 HEM A 501 NA 73.0 REMARK 620 3 HEM A 501 NB 94.9 92.0 REMARK 620 4 HEM A 501 NC 100.0 172.1 84.9 REMARK 620 5 HEM A 501 ND 84.0 91.6 175.7 91.3 REMARK 620 6 RCQ A 502 N03 160.6 88.0 81.5 98.7 100.8 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 346 NE2 REMARK 620 2 HEM B 501 NA 77.4 REMARK 620 3 HEM B 501 NB 90.6 91.0 REMARK 620 4 HEM B 501 NC 93.1 170.4 87.7 REMARK 620 5 HEM B 501 ND 84.8 86.9 175.3 93.6 REMARK 620 6 RCQ B 502 N03 164.6 92.8 77.4 96.1 106.9 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6R63 RELATED DB: PDB REMARK 900 SAME PROTEIN WITH SIMILAR LIGAND REMARK 900 RELATED ID: 7AH6 RELATED DB: PDB REMARK 900 SAME CITATION REMARK 900 RELATED ID: 7AH4 RELATED DB: PDB REMARK 900 SAME CITATION DBREF 7AH5 A 1 403 UNP P14902 I23O1_HUMAN 1 403 DBREF 7AH5 B 1 403 UNP P14902 I23O1_HUMAN 1 403 SEQADV 7AH5 MET A -19 UNP P14902 INITIATING METHIONINE SEQADV 7AH5 GLY A -18 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER A -17 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER A -16 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS A -15 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS A -14 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS A -13 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS A -12 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS A -11 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS A -10 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER A -9 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER A -8 UNP P14902 EXPRESSION TAG SEQADV 7AH5 GLY A -7 UNP P14902 EXPRESSION TAG SEQADV 7AH5 LEU A -6 UNP P14902 EXPRESSION TAG SEQADV 7AH5 VAL A -5 UNP P14902 EXPRESSION TAG SEQADV 7AH5 PRO A -4 UNP P14902 EXPRESSION TAG SEQADV 7AH5 ARG A -3 UNP P14902 EXPRESSION TAG SEQADV 7AH5 GLY A -2 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER A -1 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS A 0 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER A 3 UNP P14902 HIS 3 CONFLICT SEQADV 7AH5 MET B -19 UNP P14902 INITIATING METHIONINE SEQADV 7AH5 GLY B -18 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER B -17 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER B -16 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS B -15 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS B -14 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS B -13 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS B -12 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS B -11 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS B -10 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER B -9 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER B -8 UNP P14902 EXPRESSION TAG SEQADV 7AH5 GLY B -7 UNP P14902 EXPRESSION TAG SEQADV 7AH5 LEU B -6 UNP P14902 EXPRESSION TAG SEQADV 7AH5 VAL B -5 UNP P14902 EXPRESSION TAG SEQADV 7AH5 PRO B -4 UNP P14902 EXPRESSION TAG SEQADV 7AH5 ARG B -3 UNP P14902 EXPRESSION TAG SEQADV 7AH5 GLY B -2 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER B -1 UNP P14902 EXPRESSION TAG SEQADV 7AH5 HIS B 0 UNP P14902 EXPRESSION TAG SEQADV 7AH5 SER B 3 UNP P14902 HIS 3 CONFLICT SEQRES 1 A 423 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 423 LEU VAL PRO ARG GLY SER HIS MET ALA SER ALA MET GLU SEQRES 3 A 423 ASN SER TRP THR ILE SER LYS GLU TYR HIS ILE ASP GLU SEQRES 4 A 423 GLU VAL GLY PHE ALA LEU PRO ASN PRO GLN GLU ASN LEU SEQRES 5 A 423 PRO ASP PHE TYR ASN ASP TRP MET PHE ILE ALA LYS HIS SEQRES 6 A 423 LEU PRO ASP LEU ILE GLU SER GLY GLN LEU ARG GLU ARG SEQRES 7 A 423 VAL GLU LYS LEU ASN MET LEU SER ILE ASP HIS LEU THR SEQRES 8 A 423 ASP HIS LYS SER GLN ARG LEU ALA ARG LEU VAL LEU GLY SEQRES 9 A 423 CYS ILE THR MET ALA TYR VAL TRP GLY LYS GLY HIS GLY SEQRES 10 A 423 ASP VAL ARG LYS VAL LEU PRO ARG ASN ILE ALA VAL PRO SEQRES 11 A 423 TYR CYS GLN LEU SER LYS LYS LEU GLU LEU PRO PRO ILE SEQRES 12 A 423 LEU VAL TYR ALA ASP CYS VAL LEU ALA ASN TRP LYS LYS SEQRES 13 A 423 LYS ASP PRO ASN LYS PRO LEU THR TYR GLU ASN MET ASP SEQRES 14 A 423 VAL LEU PHE SER PHE ARG ASP GLY ASP CYS SER LYS GLY SEQRES 15 A 423 PHE PHE LEU VAL SER LEU LEU VAL GLU ILE ALA ALA ALA SEQRES 16 A 423 SER ALA ILE LYS VAL ILE PRO THR VAL PHE LYS ALA MET SEQRES 17 A 423 GLN MET GLN GLU ARG ASP THR LEU LEU LYS ALA LEU LEU SEQRES 18 A 423 GLU ILE ALA SER CYS LEU GLU LYS ALA LEU GLN VAL PHE SEQRES 19 A 423 HIS GLN ILE HIS ASP HIS VAL ASN PRO LYS ALA PHE PHE SEQRES 20 A 423 SER VAL LEU ARG ILE TYR LEU SER GLY TRP LYS GLY ASN SEQRES 21 A 423 PRO GLN LEU SER ASP GLY LEU VAL TYR GLU GLY PHE TRP SEQRES 22 A 423 GLU ASP PRO LYS GLU PHE ALA GLY GLY SER ALA GLY GLN SEQRES 23 A 423 SER SER VAL PHE GLN CYS PHE ASP VAL LEU LEU GLY ILE SEQRES 24 A 423 GLN GLN THR ALA GLY GLY GLY HIS ALA ALA GLN PHE LEU SEQRES 25 A 423 GLN ASP MET ARG ARG TYR MET PRO PRO ALA HIS ARG ASN SEQRES 26 A 423 PHE LEU CYS SER LEU GLU SER ASN PRO SER VAL ARG GLU SEQRES 27 A 423 PHE VAL LEU SER LYS GLY ASP ALA GLY LEU ARG GLU ALA SEQRES 28 A 423 TYR ASP ALA CYS VAL LYS ALA LEU VAL SER LEU ARG SER SEQRES 29 A 423 TYR HIS LEU GLN ILE VAL THR LYS TYR ILE LEU ILE PRO SEQRES 30 A 423 ALA SER GLN GLN PRO LYS GLU ASN LYS THR SER GLU ASP SEQRES 31 A 423 PRO SER LYS LEU GLU ALA LYS GLY THR GLY GLY THR ASP SEQRES 32 A 423 LEU MET ASN PHE LEU LYS THR VAL ARG SER THR THR GLU SEQRES 33 A 423 LYS SER LEU LEU LYS GLU GLY SEQRES 1 B 423 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 423 LEU VAL PRO ARG GLY SER HIS MET ALA SER ALA MET GLU SEQRES 3 B 423 ASN SER TRP THR ILE SER LYS GLU TYR HIS ILE ASP GLU SEQRES 4 B 423 GLU VAL GLY PHE ALA LEU PRO ASN PRO GLN GLU ASN LEU SEQRES 5 B 423 PRO ASP PHE TYR ASN ASP TRP MET PHE ILE ALA LYS HIS SEQRES 6 B 423 LEU PRO ASP LEU ILE GLU SER GLY GLN LEU ARG GLU ARG SEQRES 7 B 423 VAL GLU LYS LEU ASN MET LEU SER ILE ASP HIS LEU THR SEQRES 8 B 423 ASP HIS LYS SER GLN ARG LEU ALA ARG LEU VAL LEU GLY SEQRES 9 B 423 CYS ILE THR MET ALA TYR VAL TRP GLY LYS GLY HIS GLY SEQRES 10 B 423 ASP VAL ARG LYS VAL LEU PRO ARG ASN ILE ALA VAL PRO SEQRES 11 B 423 TYR CYS GLN LEU SER LYS LYS LEU GLU LEU PRO PRO ILE SEQRES 12 B 423 LEU VAL TYR ALA ASP CYS VAL LEU ALA ASN TRP LYS LYS SEQRES 13 B 423 LYS ASP PRO ASN LYS PRO LEU THR TYR GLU ASN MET ASP SEQRES 14 B 423 VAL LEU PHE SER PHE ARG ASP GLY ASP CYS SER LYS GLY SEQRES 15 B 423 PHE PHE LEU VAL SER LEU LEU VAL GLU ILE ALA ALA ALA SEQRES 16 B 423 SER ALA ILE LYS VAL ILE PRO THR VAL PHE LYS ALA MET SEQRES 17 B 423 GLN MET GLN GLU ARG ASP THR LEU LEU LYS ALA LEU LEU SEQRES 18 B 423 GLU ILE ALA SER CYS LEU GLU LYS ALA LEU GLN VAL PHE SEQRES 19 B 423 HIS GLN ILE HIS ASP HIS VAL ASN PRO LYS ALA PHE PHE SEQRES 20 B 423 SER VAL LEU ARG ILE TYR LEU SER GLY TRP LYS GLY ASN SEQRES 21 B 423 PRO GLN LEU SER ASP GLY LEU VAL TYR GLU GLY PHE TRP SEQRES 22 B 423 GLU ASP PRO LYS GLU PHE ALA GLY GLY SER ALA GLY GLN SEQRES 23 B 423 SER SER VAL PHE GLN CYS PHE ASP VAL LEU LEU GLY ILE SEQRES 24 B 423 GLN GLN THR ALA GLY GLY GLY HIS ALA ALA GLN PHE LEU SEQRES 25 B 423 GLN ASP MET ARG ARG TYR MET PRO PRO ALA HIS ARG ASN SEQRES 26 B 423 PHE LEU CYS SER LEU GLU SER ASN PRO SER VAL ARG GLU SEQRES 27 B 423 PHE VAL LEU SER LYS GLY ASP ALA GLY LEU ARG GLU ALA SEQRES 28 B 423 TYR ASP ALA CYS VAL LYS ALA LEU VAL SER LEU ARG SER SEQRES 29 B 423 TYR HIS LEU GLN ILE VAL THR LYS TYR ILE LEU ILE PRO SEQRES 30 B 423 ALA SER GLN GLN PRO LYS GLU ASN LYS THR SER GLU ASP SEQRES 31 B 423 PRO SER LYS LEU GLU ALA LYS GLY THR GLY GLY THR ASP SEQRES 32 B 423 LEU MET ASN PHE LEU LYS THR VAL ARG SER THR THR GLU SEQRES 33 B 423 LYS SER LEU LEU LYS GLU GLY HET HEM A 501 43 HET RCQ A 502 13 HET RCQ A 503 13 HET HEM B 501 43 HET RCQ B 502 13 HET RCQ B 503 13 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM RCQ 4-CHLORANYL-2-(1~{H}-1,2,4-TRIAZOL-5-YL)ANILINE HETSYN HEM HEME HETSYN RCQ MMG-0706 FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 RCQ 4(C8 H7 CL N4) HELIX 1 AA1 PRO A 33 PHE A 35 5 3 HELIX 2 AA2 TYR A 36 HIS A 45 1 10 HELIX 3 AA3 HIS A 45 SER A 52 1 8 HELIX 4 AA4 GLN A 54 LYS A 61 1 8 HELIX 5 AA5 SER A 66 LEU A 70 5 5 HELIX 6 AA6 ASP A 72 GLY A 93 1 22 HELIX 7 AA7 PRO A 104 GLU A 119 1 16 HELIX 8 AA8 VAL A 125 VAL A 130 1 6 HELIX 9 AA9 THR A 144 GLU A 146 5 3 HELIX 10 AB1 CYS A 159 SER A 176 1 18 HELIX 11 AB2 ALA A 177 LYS A 179 5 3 HELIX 12 AB3 VAL A 180 GLN A 191 1 12 HELIX 13 AB4 GLU A 192 PHE A 214 1 23 HELIX 14 AB5 GLN A 216 VAL A 221 1 6 HELIX 15 AB6 ASN A 222 VAL A 229 1 8 HELIX 16 AB7 VAL A 229 SER A 235 1 7 HELIX 17 AB8 SER A 263 GLN A 266 5 4 HELIX 18 AB9 SER A 267 LEU A 277 1 11 HELIX 19 AC1 GLY A 286 MET A 295 1 10 HELIX 20 AC2 ARG A 296 MET A 299 5 4 HELIX 21 AC3 PRO A 300 ASN A 313 1 14 HELIX 22 AC4 SER A 315 LYS A 323 1 9 HELIX 23 AC5 ASP A 325 ILE A 354 1 30 HELIX 24 AC6 ILE A 354 SER A 359 1 6 HELIX 25 AC7 THR A 382 LYS A 397 1 16 HELIX 26 AC8 PRO B 33 PHE B 35 5 3 HELIX 27 AC9 TYR B 36 HIS B 45 1 10 HELIX 28 AD1 HIS B 45 GLU B 51 1 7 HELIX 29 AD2 GLN B 54 LEU B 62 1 9 HELIX 30 AD3 HIS B 73 GLY B 93 1 21 HELIX 31 AD4 PRO B 104 LYS B 116 1 13 HELIX 32 AD5 VAL B 125 VAL B 130 1 6 HELIX 33 AD6 CYS B 159 ALA B 175 1 17 HELIX 34 AD7 SER B 176 LYS B 179 5 4 HELIX 35 AD8 VAL B 180 MET B 190 1 11 HELIX 36 AD9 GLU B 192 PHE B 214 1 23 HELIX 37 AE1 GLN B 216 VAL B 221 1 6 HELIX 38 AE2 ASN B 222 VAL B 229 1 8 HELIX 39 AE3 VAL B 229 LEU B 234 1 6 HELIX 40 AE4 SER B 263 GLN B 266 5 4 HELIX 41 AE5 SER B 267 LEU B 277 1 11 HELIX 42 AE6 GLY B 286 MET B 295 1 10 HELIX 43 AE7 ARG B 296 MET B 299 5 4 HELIX 44 AE8 PRO B 300 SER B 312 1 13 HELIX 45 AE9 SER B 315 LYS B 323 1 9 HELIX 46 AF1 ASP B 325 ILE B 354 1 30 HELIX 47 AF2 ILE B 354 GLN B 360 1 7 HELIX 48 AF3 GLY B 381 LYS B 397 1 17 SHEET 1 AA1 2 VAL A 102 LEU A 103 0 SHEET 2 AA1 2 VAL A 248 TYR A 249 1 O VAL A 248 N LEU A 103 SHEET 1 AA2 2 LYS A 135 LYS A 136 0 SHEET 2 AA2 2 MET A 148 ASP A 149 -1 O ASP A 149 N LYS A 135 SHEET 1 AA3 2 VAL B 102 LEU B 103 0 SHEET 2 AA3 2 VAL B 248 TYR B 249 1 O VAL B 248 N LEU B 103 SHEET 1 AA4 2 LYS B 135 LYS B 136 0 SHEET 2 AA4 2 MET B 148 ASP B 149 -1 O ASP B 149 N LYS B 135 SSBOND 1 CYS A 308 CYS B 308 1555 1555 2.04 LINK NE2 HIS A 346 FE HEM A 501 1555 1555 2.52 LINK FE HEM A 501 N03 RCQ A 502 1555 1555 1.95 LINK NE2 HIS B 346 FE HEM B 501 1555 1555 2.45 LINK FE HEM B 501 N03 RCQ B 502 1555 1555 1.94 CRYST1 84.988 93.106 130.360 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011766 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010740 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007671 0.00000